|
Název CD znaku a
odkaz na jeho popis |
Synonymum |
Molekulová
hmotnost |
|
CD1A,T6/leu-6,
R4, HTA1 |
49 |
|
|
CD1B,
R1 |
45 |
|
|
CD1C,
M241, R7 |
43 |
|
|
CD1D,
R3 |
38 |
|
|
CD1E,
HSCDIEL |
36 |
|
|
SRBC,T11,
LFA-2 |
50/50 |
|
|
T3,
CD3 komplex (?,?,?,? ) |
25 |
|
|
T3,
CD3 komplex (?,?,?,? ) |
20 |
|
|
T3,
CD3 komplex (?,?,?,? ) |
20 |
|
|
T3,
CD3 komplex (?,?,?,? ) |
16 |
|
|
T4,
OKT4 |
55 |
|
|
Tp67,
T1 |
58/67 |
|
|
T12 |
105
a 130 |
|
|
3A1,
gp40 |
40 |
|
|
T8,
Leu-2 |
68/32-34 |
|
|
T8 |
68/30-32 |
|
|
p24,
24 |
24/24-26 |
|
|
MME,
CALLA, NEP |
100/100 |
|
|
ITGAL,
LFA-1a |
170/180 |
|
|
ITGAM,
Mac-1a |
165/170 |
|
|
ITGAX,
p150, 95a |
145/150 |
|
|
p90-120 |
150-160/120 |
|
|
ANPEP,
LAP1,PEPN, gp150 |
150 |
|
|
LPS-R |
53/55 |
|
|
Lewis
X, FUT4, CD15u, CD15s, CD15su |
Variabilní |
|
|
Variabilní |
||
|
FcgRIIIA,
FCGR3A |
50-65 |
|
|
FcgRIIIB,
FCGR3B |
/48 |
|
|
laktosylceramid,
LacCer |
||
|
LAD,LFA-1,LCAMB,
integrin |
90/95 |
|
|
B4,
Bgp95 |
120/95 |
|
|
B1
antigen, Bgp35, 33,35 |
37/35 |
|
|
C3DR,
CR2, EBV-R, gp140 |
145/110 |
|
|
BL-CAM,
SIGLEC2 |
140/130 |
|
|
FCER2,
FceRII, FCE2, Blast-2 |
45/45 |
|
|
BA-1,
HSA |
35-45 |
|
|
IL-2Ra,
Tac |
55/55 |
|
|
EC3.4.14.5,DPP
IV |
120/110 |
|
|
T14,
S152 |
110-120/55 |
|
|
Tp44,
T44 |
90/44 |
|
|
ITGB1,
MDF2, GPIIA,VLAb |
110/130 |
|
|
Ki-1
antigen, Kl-1, TNFRSF8 |
120/105 |
|
|
PECAM-1 |
~135/135 |
|
|
FCGR2A,
FCG2,, FcGR, gp40 |
40/42 |
|
|
SIGLEC3,
My9, p67 |
150/67 |
|
|
gp
105-120, My10 |
~
105-120 |
|
|
CR1,
C3b/C4bR |
160-250 |
|
|
GPIV,
FAT,OKM-5 |
90/85 |
|
|
gp52-40,
Tspan-26 |
40-52/40-52 |
|
|
T10,
ADP-ribosyl cyklaza |
45/45 |
|
|
ENTPD1,gp80,
E-ATPDaza |
80/80 |
|
|
Bp50,
TNF receptor 5 |
48-85 |
|
|
ITGA2B,integrin
aIIb |
135/120/23 |
|
|
GP9,
GPIX, gp9 |
22/17
- 22 |
|
|
GP1BA,
GPIb-a |
160/145 |
|
|
GP1BB,
GPIb-b |
160/24 |
|
|
GP5,
GPV |
82/82 |
|
|
SPN,
LSN, sialoforin |
95-135/95-135 |
|
|
Pgp-1,
formy CD44R,CD44v1-10 |
90 |
|
|
PTPRC,LCA,
RB, RC, RO |
180-220/ |
|
|
MCP |
52-58/62-68 |
|
|
IAP,
OA3, MER6 |
45-60/50-55 |
|
|
BLAST?1,OX45,
BCM1 |
45/45 |
|
|
ITGA1,
VLA-1a |
200/200 |
|
|
ITGA2,
VLA-2a |
150/160 |
|
|
ITGA3,VLA-3a |
150/125,
30 |
|
|
ITGA4,VLA-4a |
145/150 |
|
|
ITGA5,VLA-5a |
160/135,25 |
|
|
ITGA6,VLA-6a |
150/125 |
|
|
ICAM-3 |
110-140/ |
|
|
ITGAV,
Integrin aV |
150/124,24 |
|
|
CAMPATH-1,
HES |
25-29/25-29 |
|
|
tetraspanin-25,
MOX44 |
32-42/ |
|
|
ICAM-1 |
90/95 |
|
|
DAF |
55-70/80 |
|
|
NCAM1,
NKH1 |
140 |
|
|
HNK1,
LEU7, NK-1 |
110-115/ |
|
|
LFA-3 |
/55-70 |
|
|
protektin,
MIRL , P-18 |
18-25/18-25 |
|
|
GD3,
3 formy: CD60a,CD60b,CD60c |
120/ |
|
|
ITGB3,
integrin b3, GPIIIa |
90/110 |
|
|
SELE,E-selektin,ELAM-1 |
115/97 |
|
|
SELL,
L-selektin, LAM-1 |
65/74-95 |
|
|
SELP,
P-selektin, GMP-140 |
120/140 |
|
|
LIMP,
LAMP-3, MLA1 |
40-60/ |
|
|
-/72 |
||
|
ceramid
(sacharid), forma CD65s |
||
|
BG
CEACAM1,BGP, NCA-160 |
/140-180 |
|
|
BG
CEACAM8, CGM6, NCA-95 |
/95-100 |
|
|
CEACAM6,
1NCA |
/90 |
|
|
CEACAM3,
1CGM-1 |
/35 |
|
|
CEACAM5,
CEA |
/180-200 |
|
|
PSG1,
PSG, Sp-1 |
/54-72 |
|
|
SCARD1,
gp110 |
110/ |
|
|
AIM |
60/28-32 |
|
|
TBFSF7,CD27
ligand |
55-170 |
|
|
TFRC,
T9 |
190/95 |
|
|
Lyb-2,
Ly-19.2 |
80-86/43 |
|
|
MT5E,
Ekto 5´- nukleotidáza |
69-72/ |
|
|
DHLAG,
Ii, 33, 35, 41, 43 |
41/ |
|
|
laktosamin,
forma:CD75s |
Různá |
|
|
BLA,
Gb3, CTH, Pk antigen |
1kD |
|
|
IGA,
MB-1, Ig-alpha, mb-1 |
/40-45 |
|
|
IGB,
Ig-beta, B29 |
/37 |
|
|
LAB7,
CD28LG,B7-1, BB1 |
60/ |
|
|
TAPA-1,
S5.7, M38 |
26/ |
|
|
SAR2,
R2, IA4 |
45-90/ |
|
|
HB15,
BL-11 |
/43 |
|
|
P75,
GR6, SLAMF5 |
68-80/72-86 |
|
|
LILRB,
ILT-5/LIR-3/HL9 |
~
60-110 |
|
|
B7-2,
B70 |
/80 |
|
|
PLAUR,
uPAR |
35-68/32-66 |
|
|
C5R1,
C5aR |
43/ |
|
|
FCAR,
IgAFcR, IgAR |
45-100/ |
|
|
THY-1 |
25-35/25-35 |
|
|
LRP-1 |
600/ |
|
|
SLC44A1,P70,
CHTL1 |
70/70 |
|
|
C1QR1,
GR11 |
110/126 |
|
|
KLRD1,
Kp43 |
70/30 |
|
|
FAS,
APO-1, Fas, APT1 |
90,
200/45 |
|
|
TACTILE,
160,180 |
160/ |
|
|
BL-KDD/F12,
CD97a |
75-85/75-85 |
|
|
SLC3A2,
4F2, FRP-1 |
125/80,
45 |
|
|
MIC2,
E2 |
32/32 |
|
|
SEMA4D,Semaforin,
4D |
300/150 |
|
|
IGSF2,
V7, P126 |
240/120 |
|
|
ICAM-2 |
55-65/ |
|
|
ITGAE,
HML-1, 150 |
175/150,
25 |
|
|
ITGB4,
integrin b4, TSP-1180 |
205/220 |
|
|
ENG,
endoglin |
180/90 |
|
|
VCAM1 |
110/110 |
|
|
LAMP1,
LAMPA |
100-120/ |
|
|
LAMP2,
LAMPB |
100-120/ |
|
|
SEMA7A,
SEMAK1, JMH |
76/80 |
|
|
FLJ38569,
8A3, E123 |
170/170 |
|
|
MPL,
MPLV, TPO-R |
82-92/ |
|
|
PVRL1,
PRR1, nektin -1 |
/75 |
|
|
PVRL2,
PRR2, 72 |
64-72/64-72 |
|
|
PVRL3,
PRR3, nektin-3 |
/130 |
|
|
CSF3R,G-CSFR,
HG-CSFR |
130-150 |
|
|
CSF1R,
M-CSFR, c-fms |
150/ |
|
|
CSF2RA,
GM-CSFRa |
80 |
|
|
KIT,CSFR,
ckit |
145/145 |
|
|
LIFR,
SWS, STWS |
190/ |
|
|
IFNGR1,IFNgRa |
80-95/ |
|
|
TNFRSF1A,
TNFR (I) |
55/ |
|
|
TNFRSF1B
, TNFR II |
75/ |
|
|
IL1R1,
IL-1R, typ I |
75-85/75-85 |
|
|
IL1R2,
IL-1R, typ II |
60-68/60-68 |
|
|
IL2RB,
IL-2Rb |
70-75/ |
|
|
IL3RA,
IL-3Ra |
70/ |
|
|
IL4R,
IL-4Ra |
140/ |
|
|
IL5RA,
IL-5Ra |
60/ |
|
|
IL6R,
IL-6Ra |
80/80 |
|
|
IL7R,
IL-7Ra, P90 |
65-90/90 |
|
|
IL-8R,
typI/II, CD181, CD182 |
44-59/67-70 |
|
|
IL-8R,
typI/II, CD181, CD182 |
44-59/67-70 |
|
|
IL9R,
IL-9 receptor alpha |
||
|
IL6R-b,
GP130, gp130, GP130-RAPS |
||
|
IL3RB,
IL5RB |
120-140/ |
|
|
IMD4,
SCIDX |
65-70/ |
|
|
AC133,
PROML1 |
120/120 |
|
|
OX40,
ACT35, CD252L |
48-50/ |
|
|
FLT3,
STK-1, FLK-2, 130/155D |
130/155-160 |
|
|
MSP-R,
RON |
180/150,
40 |
|
|
4-1BB,
ILA, MGC2172 |
85/39 |
|
|
syndekan-1,
B-B4, SDC |
/80-150 |
|
|
/209-238 |
||
|
PTGFa
receptor, PTGFR2 |
160,180/ |
|
|
PTGFb
receptor, PTGFR1 |
160-180/ |
|
|
trombomodulin,
THRM, TM |
160-180/ |
|
|
tkáňový
faktor, TF, TFA |
45-47 |
|
|
ACA,
ACE1, DCP1 |
170-180/170-180 |
|
|
7B4,VE-kadherin,
kadherin 5 |
135/130 |
|
|
25,90,
110/25, 90, |
||
|
MUC18,
MCAM, s-endo |
118/130 |
|
|
EMMPRIN,
basigin, BSG |
50-60/55-65 |
|
|
HPTPh,
DEP-1, PTPRJ |
240-260/240-260 |
|
|
SLAM-1,
IPO-3 |
65-85/75-95 |
|
|
PETA-3,
SFA-1, Tspan-24, 28 |
32/ |
|
|
CTLA-4 |
50/33 |
|
|
CD30L,
TNFSF8, CD30LG |
70-75/38-40 |
|
|
CD40L,
CD40LG, TRAP, gp39 |
33/33,30,28 |
|
|
PVR,
PVS, nectin-like 5 |
80-90/ |
|
|
ADAM
8, MS2 |
/69 |
|
|
TACE,
ADAM17 |
/100-120 |
|
|
ADAM10,
MADM |
65/79 |
|
|
BST-1,
BP-3/IF7 |
42-45/42-45 |
|
|
KIR2DL1p |
58-70/50-140 |
|
|
NKG2a,
KLRC1 |
43 |
|
|
NKG
2C, KLRC2 |
36 |
|
|
BY55,NK1,NK28 |
80/27 |
|
|
80/40 |
||
|
220-240/110-140 |
||
|
110 |
||
|
160/80 |
||
|
37/42 |
||
|
100/105/100-105 |
||
|
125 |
||
|
130 |
||
|
/56-58 |
||
|
SN,
sialoadhezin, SIGLEC1 |
180/200 |
|
|
SIGLEC5,
CD33L2, OB-BP2 |
140 |
|
|
L1CAM,
LI, MIC5, MASA |
200-230 |
|
|
SIRPa,
PTPNS1, MFR, SIRP |
85-90 |
|
|
SIRPB1,
SIRP-beta-1 |
110-120 |
|
|
SIRPB2,
SIRP beta 2 |
55 |
|
|
Krevní
skupina H2 (karbohydrát) |
||
|
Lewis
Y krevní skupina, FUT3, LE,Les |
||
|
Tn
antigen (karbohydrát) |
||
|
sialyl-Tn,
prekurzor ABO antigenů |
||
|
TF,
Thomsen-Friedenreich antigen |
120-198 |
|
|
NB1,
HNA2A |
49-55/56-64 |
|
|
FAS
ligand, FASLG, TNFSF6 |
/30-40 |
|
|
VPREB1,
IGVPB, IGI |
/16-18 |
|
|
IGLL1,
IGL1, IGO, IGVPB |
/22 |
|
|
RP105,
Bgp95, LY64 |
95-105/95-105 |
|
|
CXCR1,
IL-8 receptor ?, IL8RBA |
||
|
CXCR2,
IL-8 receptor ?, IL8RA |
||
|
CXCR3,
CMKAR3, GPR9, IP10 |
/40-41 |
|
|
CXCR4,
LESTR, LAP3, VHIM |
46/46 |
|
|
CXCR5,
MDR15, BLR1 |
||
|
CXCR6,
BONZO |
39 |
|
|
CCR1,
CKR1, MIP1aR |
41 |
|
|
CCR2,
CKR2, MCP-1-R |
42 |
|
|
CCR3,
CKR3, CMKBR3 |
41 |
|
|
CCR4,
CKR4, CMKBR4, 41 |
41,4 |
|
|
CCR5,
CKR5, CMKBR5 |
37/40,6 |
|
|
CCR6,
CKR6, CMKBR6, BH-1 |
42 |
|
|
CCR7,
BLR2, CMKBR7 |
90 |
|
|
CCR8,
CMKBR8, CKR-L1, TER1 |
41 |
|
|
CCR9,
GPR-28 |
42 |
|
|
OX2,
MRC, MOX1 |
40-45 |
|
|
PROCR,
CCCA,EPCR |
49/25 |
|
|
TIE2,
VMCM, TEK |
140/140 |
|
|
E-NPP3,
B10, NPP3, PDNP3, 270/130 |
270/130-150 |
|
|
MSR1,
SCARA1, SR-A, phSR1 |
220 |
|
|
DEC205,
LY75, CLEC13B |
205/ |
|
|
MRC1,
CLEC13D, R |
162-175/ |
|
|
langerin |
40/40 |
|
|
LAMP3,
DC-LAMP |
70-90 |
|
|
CDSIGN,DC-SIGN |
/44 |
|
|
IL10RA,
IL10R1 |
90 |
|
|
IL10RB,
IL10R2, |
90 |
|
|
IL12R-beta1,
IL12RB, IL12R |
110 |
|
|
IL13RA1,
IL13Ra1, NR4 |
||
|
IL13RA1,
IL13Ra2, IL13BP |
||
|
IL17R,
IL17R, hl17R |
||
|
IL18R1,
ILRRP,IL-1Rrp |
62 |
|
|
IL18RAP,
ACPL |
68 |
|
|
INSR |
400 |
|
|
IGF1R,
JTK13 |
135+90 |
|
|
IGF2R,
CIMPR, MPR1 |
250/300 |
|
|
LAG3 |
70/70 |
|
|
GGT1,
GTG |
55+25/100 |
|
|
IFITM1,
Sep-27, Leu1-13 |
17 |
|
|
DNAM-1,
PTA1, TLiSA1 |
/65 |
|
|
MUC
1, EMA, PEM, DF3 |
220-700 |
|
|
MF12,
MAP97, MTF1, p97 |
80-90 |
|
|
LY9,
SLAMF3, mLY9, Ly9 |
120 |
|
|
PRNP,
ASCR, CJD, GSS, PrPc |
30-40 |
|
|
TSPAN7,
TALLA-1 TM4SF2 |
30-45 |
|
|
PLXNC1,VESPR,
Plexin |
200 |
|
|
SLC4A1,Band3,
AE1 |
95-105/95-105 |
|
|
DARC,
CCBP1, Duffy skupina |
35-43/36 |
|
|
GYPA,GPA,
PAS-2, MN |
30m,
65d |
|
|
GYPB,
GPB, PAS-3, MNS |
||
|
GYPC,
GPC, GE |
30-40 |
|
|
40 |
||
|
KEL,
Kell (krevní skupina) |
115-200/93 |
|
|
LU,
BCAM, AU, MSK19 |
78-85 |
|
|
RHCE,Rh30CE,
RHE, Rh4 |
30 |
|
|
RHD,
Rh30, RHCET, RHP1 |
30 |
|
|
30 |
||
|
RHAG,
RH2, RH50A |
50 |
|
|
ICAM4,
LW krevní skupina |
42 |
|
|
ABCB1,MDR-1,
PGP 170 |
170-180/170-180 |
|
|
2B4,
NAIL, SLAMF4 |
70/70 |
|
|
p220/240,
DY12 |
220-250 |
|
|
ALK |
200 |
|
|
CD3-zeta
řetězec, (TCR), CD3? |
16 |
|
|
TEM1,
endosialin, CD164L1 |
175 |
|
|
ENPEP,
APA, EAP, BP-1, gp160 |
160 |
|
|
TNFSF4,
GP34, OX40L, TXGP1 |
34 |
|
|
TNFSF10,
TRAIL, APO2L |
32,5 |
|
|
TNFSF11,
TRANCE, RANKL |
34,5 |
|
|
TNFSF13,
APRIL, TALL2 |
27,5 |
|
|
TNFSF13B,
BLYS, BAFF,TALL1 |
31 |
|
|
TNFSF14,
LIGHT, HVEML, TR2 |
29 |
|
|
TNFRSF10A,TRAILR1,
DR4 |
50 |
|
|
TNFRSF10B,TRAIL-R2,
DR5 |
48 |
|
|
TNFRSF10C,TRAIL-R3,
DCR1 |
65 |
|
|
TNFRSF10D,TRAIL-R4,
DCR2 |
35 |
|
|
TNFRSF11A,RANK,
EOF |
97 |
|
|
TNFRSF12A,
TWEAKR, FN14 |
14 |
|
|
TNFRSF13B,
TACI, CVID |
32 |
|
|
TNFRSF13C,
BAFFR, BR3 |
||
|
TNFRSF17,
BCMA,BCM |
27 |
|
|
30 |
||
|
NGFR
, TNFRSF16, NTR |
75 |
|
|
BTLA,
BTLA1 |
33 |
|
|
PDCD1LG2,
B7DC, PD-L2 |
25 |
|
|
B7-H1,
PD-L1, PDCD1L1 |
40 |
|
|
B7H2,
ICOSLG, GL50, LICOS |
||
|
B7H3 |
110
a 40-45 |
|
|
BTN3A1,
BT3.1, BTF5 |
56 |
|
|
ICOS,
AILIM |
55-60d |
|
|
PDC1D1,
PD1, hPD-1, SLEB2 |
55 |
|
|
MRC2,
Endo180, TEMM22 |
180 |
|
|
TLR1,
Toll-like receptor 1, TIL |
90 |
|
|
TLR2,
Toll-like receptor 2 |
85 |
|
|
TLR3,
Toll-like receptor 3 |
100 |
|
|
TLR4,
Toll-like receptor 4 |
85 |
|
|
120 |
||
|
TLR6,
Toll-like receptor 6 |
85 |
|
|
TLR8,
Toll-like receptor 8 |
83 |
|
|
TLR9,
Toll-like receptor 9 |
115-120 |
|
|
TLR10,
Toll-like receptor 10 |
91-100 |
|
|
97 |
||
|
BMPR1A,
ALK-3, ACVRLK3 |
50-58 |
|
|
BMPR1B,
ALK6 |
50-58 |
|
|
GPR44,
CRTH2 |
43 |
|
|
LEPR,
LeptinR, OBR |
130-150 |
|
|
ART1,
ART2, RT6 |
37 |
|
|
ART4,DO,
DOK, Dombrock skupina |
38 |
|
|
ATP1B3,
ATPB-3 |
32 |
|
|
CLEC4M,
LSIGN, DC-SIGNR |
40,1 |
|
|
CMRF35H,
IRC1, IRp60 |
60 |
|
|
CMRF35A,
LIR |
23 |
|
|
CLEC10A,
HML, HML2 |
38 |
|
|
DCL1,
BIMLEC |
30 |
|
|
CLEC4C,BDCA2,
DLEC, HECL |
38 |
|
|
NRP1,
VEGF165R |
140 |
|
|
LAIR1,
Ig ? like receptor 1 |
31 |
|
|
LAIR2,
Ig-like receptor 2 |
16 |
|
|
FCRL5,
BXMAS1 |
100 |
|
|
152 |
||
|
KDR,
FLK1,VEGFR2 |
230 |
|
|
146 |
||
|
98 |
||
|
EMR2 |
90 |
|
|
KLRK1,
KLR,NKG2D |
42 |
|
|
PTGFRN,CD9P1,
KIAA1436 |
135 |
|
|
IGSF8,
EWI-2, CD81P3, ECl2 |
63 |
|
|
BST2,HM1.24 |
29-33 |
|
|
CDCP1,
SIMA135 |
140 |
|
|
SLAMF7,
CRACC, CS1, 19A |
66 |
|
|
8D6,
8D6A |
29 |
|
|
F11R,
JAM1, KAT, PAM |
32-35 |
|
|
JAM2,
VEJAM, C21orf43 |
45 |
|
|
43 |
||
|
CDH1,
E-kadherin, Arc-1, CDHE |
120 |
|
|
CDH2,
N-kadherin, NCAD |
140 |
|
|
TACSTD1,Ep-CAM,
EGP40 |
40 |
|
|
SIGLEC6,
CD33L, Ig-like lectin 6 |
49 |
|
|
SIGLEC7,
Ig-like lectin 7, AIRM |
75 |
|
|
SIGLEC9,
Ig-like lectin 9, 50 |
50,1 |
|
|
90-120 |
||
|
FGFR1,
FLT2, C-FGR, N-SAM |
130 |
|
|
FGFR2,
TK14, BEK, K-SAM |
115-135 |
|
|
FGFR3,
JTK4 |
115-135 |
|
|
FGFR4,
JTK2 |
110 |
|
|
NCR1,
NKp46, Ly94 |
46 |
|
|
NCR2,
NKp44, NKP44, Ly95 |
44 |
|
|
NCR3,
NKp30, NCR3, Ly117 |
30 |
|
|
ABCG2,
MRX, MXR, ABC15 |
72 |
|
|
JAG-1,
Jagged-1, JAGL-1, AGS |
150 |
|
|
ERBB2,
HER2/neu, NEU,NGL |
185 |
|
|
FZD4,
Frizzled -4, EVR1, Fz-4 |
59,8 |
|
|
FZD9,
Fz9, hFz9, FZD3 |
64,5 |
|
|
FZD10,
Fz10, hFz10 |
65,3 |
Další informace
Kristián Koubek,
2011-11-23